Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Participant Experiences of Microdosed Lysergic Acid Diethylamide in a 6-Week Randomised Controlled Trial

Datos Bibliográficos

ID9020599
AutoresRobin J Murphy (0000-0002-9571-0050, University of Auckland, autor de correspondencia), Mia Wardlaw (Te Whatu Ora, Health New Zealand, Wellington, New Zealand), Thomas Smith (0000-0002-3650-9381), Todd Smith (Te Whatu Ora, Health New Zealand, Wellington, New Zealand), T Noorani (0000-0002-4185-0218, University of Auckland), William Evans (0000-0002-8916-2684, Mana Health, Auckland, New Zealand), William J Evans (0000-0001-6757-1471), Lisa Reynolds (0000-0002-9609-2135, University of Auckland), David B Menkes (0000-0003-3760-7896, University of Auckland), Rachael L Sumner (0000-0002-2652-4617, University of Auckland), Suresh Muthukumaraswamy (0000-0001-7042-3920, University of Auckland), Suresh D Muthukumaraswamy (University of Auckland)
Año2025
Fecha de publicación2025-11-10
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaJournal of Humanistic Psychology (JOURNAL)
Identificadores de la revistaISSN: 0022-1678 • E-ISSN: 1552-650X
EditorialSAGE Publishing (PUBLISHER • US)
DOI10.1177/00221678251382624
OpenAlexW4416070182
IdiomaEN
Referencias citadas64

Microdosing psychedelics is an increasingly popular phenomenon where small amounts of psychedelic drugs are taken regularly. Qualitative data have been published regarding the experiences of microdosers, but never in the context of a randomised controlled trial. Semi-structured video interviews with 40 healthy males were conducted following a double-blind placebo-controlled trial of 10 μg of lysergic acid diethylamide every third day for 6 weeks. Data were analysed using content analysis with initial deductive categories derived from the literature populated with inductively derived codes. Drug effects were classified in the following categories: “emotions and mood,” “social life,” “mindfulness,” “cognition, work, and creativity,” and “physiological effects,” with an additional “influences” code for non-drug modifiers of participants experiences in the trial. Themes which spanned these categories were openness to experiences and a bidirectionality of effects. Some identified codes have potential clinical relevance and may support the use of microdosing in treatment of mood disorders. Reports of changes in anxiety suggest important considerations in selecting appropriate patients and doses. Of relevance to psychedelic clinical trial design are participants’ reports regarding set and setting, the uncertainty caused by participating in a placebo-controlled trial, and perceived bidirectionality of effects

Anxiety · Context (archaeology · Lysergic acid diethylamide · Mood · Openness to experience · Qualitative research · Randomized controlled trial · Relevance (law · Forensic Toxicology and Drug Analysis · Psychedelics and Drug Studies · Substance Abuse Treatment and Outcomes

  • Depression and Social Identity

    Open Access•Tegan Cruwys, Alexander Haslam et al.•Personality and Social Psychology…•2014

  • Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

    Open Access•Katherine A Maclean, Matthew W Johnson et al.•Journal of Psychopharmacology•2011

  • Twelve tips for conducting qualitative research interviews

    Open Access•Cormac McGrath, Per J Palmgren et al.•Medical Teacher•2019

  • A hands-on guide to doing content analysis

    Open Access•Christen Erlingsson, Petra Brysiewicz•African Journal of Emergency…•2017

  • Constructing drug effects

    Open Access•Ido Hartogsohn•Drug Science, Policy and Law•2017

  • Mindfulness and self-acceptance

    Open Access•Shelley Carson, Shelley H Carson et al.•Journal of Rational-Emotive and…•2006

  • The qualitative content analysis process

    Open Access•Satu Elo, Helvi Kyngäs•Journal of Advanced Nursing•2008

  • Mindfulness

    Open Access•Scott R Bishop, Mark A Lau et al.•Clinical Psychology: Science and…•2004

  • How to plan and perform a qualitative study using content analysis

    Open Access•Mariette Bengtsson•NursingPlus Open•2016

  • Content analysis and thematic analysis

    Open Access•Mojtaba Vaismoradi, Hannele Turunen et al.•Nursing & Health Sciences•2013

  • Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers

    Open Access•Nadia R P W Hutten, Natasha L Mason et al.•Frontiers in Psychiatry•2019

  • Microdosing psychedelics

    Open Access•Toby Lea, Nicole Amada et al.•International Journal of Drug…•2020

  • Narrative identity, rationality, and microdosing classic psychedelics

    Open Access•Megan Webb, H Copes et al.•International Journal of Drug…•2019

  • Psychedelic Drug Microdosing Practices

    Open Access•Estelle Miller, Vida Bojovic et al.•Journal of Psychoactive Drugs•2024

  • Psychedelic Microdosing

    Lindsay P Cameron, Angela Nazarian et al.•Journal of Psychoactive Drugs•2020

  • Psychedelic Microdosing

    Toby Lea, Nicole Amada et al.•Journal of Psychoactive Drugs•2019

  • Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration

    James Fadiman, Sophia Korb•Journal of Psychoactive Drugs•2019

  • Microdosing as a Response to the Meaning Crisis

    Open Access•Rotem Petranker, Juensung J Kim et al.•Journal of Humanistic Psychology•2022

Velocidad de citaciónhistorical
Altamente citadoNo
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae